Form 4: Inspire Medical Systems Executive Reports Stock Award and Tax Withholding
SEC Form 4 Filing
John Rondoni, Chief Technology Officer of Inspire Medical Systems, reports the acquisition of 3,296 shares of common stock due to vesting of performance stock units and the disposal of 1,009 shares for tax obligations.
Summary
- On February 24, 2025, John Rondoni, the Chief Technology Officer of Inspire Medical Systems, acquired 3,296 shares of common stock due to the vesting of previously granted performance stock units.
- On the same day, 1,009 shares were withheld by Inspire Medical Systems to cover taxes related to the vesting of the performance stock unit award at a price of $186.45 per share.
- Following these transactions, Rondoni directly owns 17,787 shares of Inspire Medical Systems common stock.
Sentiment
Score: 5
Explanation: This is a routine filing related to executive compensation. It's neither particularly positive nor negative.
Positives
- The vesting of performance stock units suggests that Rondoni has met certain performance criteria, which could be viewed positively.
Industry Context
Executive compensation and stock ownership are standard practices in publicly traded companies to align management's interests with those of shareholders. Form 4 filings are a routine part of this process.
Stakeholder Impact
- The transaction has a minor impact on shareholders as it reflects changes in executive ownership.
Key Dates
| Date | Description |
|---|---|
| 02/24/2025 | Date of stock award and tax withholding. |
| 02/25/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.